Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TATA-box binding protein associated factor 2 (TAF2) is a protein encoded by the *TAF2* gene in humans and is a major subunit of the transcription factor IID (TFIID) complex. TFIID is essential for the initiation of transcription by RNA polymerase II, serving as a scaffold for the assembly of the pre-initiation complex and a conduit for regulatory signals during promoter activation. TAF2 is stably associated with TFIID and contributes to promoter DNA binding, interacting at and downstream of transcription start sites to facilitate transcription complex responsiveness to activators. Structurally, TAF2 contains a histone-like fold domain, contributing to protein-protein interactions within TFIID. Pathogenic variants in TAF2 can result in neurodevelopmental disorders, including leukodystrophy. TAF2 is not a direct therapeutic target and no drugs are known to modulate its activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TATA-box binding protein associated factor 2 (TAF2).